Quantitative evaluation of synbiotic strategies to improve persistence and metabolic activity of Lactobacillus reuteri DSM 17938 in the human gastrointestinal tract

Journal of Functional Foods

Volumn 10, Issue , 2014, Pages 85-94

  Rattanaprasert, Monchaya ^a   Roos, Stefan ^b   Hutkins, Robert W ^a   Walter, Jens ^a,c  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

1,2 Propanediol; Galactooligosaccharide; Lactobacillus reuteri; Probiotic; Rhamnose; Synbiotic

Indexed keywords

BACTERIA (MICROORGANISMS); LACTOBACILLUS REUTERI;

EID: 84920029204     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.05.017     Document Type: Article

References (65)

1. Abrahamsson T.R., Jakobsson T., Böttcher M.F., Fredrikson M., Jenmalm M.C., Björkstén B., Oldaeus G. Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. The Journal of Allergy and Clinical Immunology 2007, 119:1174-1180.
2. Agustina R., Kok F.J., van de Rest O., Fahmida U., Firmansyah A., Lukito W., Feskens E.J., van den Heuvel E.G., Albers R., Bovee-Oudenhoven I.M. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics 2012, 129:e1155-e1164.
3. Al-Sheraji S.H., Ismail A., Manap M.Y., Mustafa S., Yusof R.M., Hassan F.A. Prebiotics as functional foods: A review. Journal of Functional Foods 2013, 5:1542-1553.
4. Alander M., Matto J., Kneifel W., Johansson M., Kogler B., Crittenden R., Mattila-Sandholm T., Saarela M. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. International Dairy Journal 2001, 11:817-825.
5. Amin H.M., Hashem A.M., Ashour M.S., Hatti-Kaul R. 1,2 Propanediol utilization by Lactobacillus reuteri DSM 20016, role in bioconversion of glycerol to 1,3 propanediol, 3-hydroxypropionaldehyde and 3-hydroxypropionic acid. Journal of Genetic Engineering and Biotechnology 2013, 11:53-59.
6. Aron-Wisnewsky J., Gaborit B., Dutour A., Clement K. Gut microbiota and non-alcoholic fatty liver disease: New insights. Clinical Microbiology and Infection 2013, 19:338-348.
7. Arsköld E., Lohmeier-Vogel E., Cao R., Roos S., Rådström P., van Niel E.W.J. Phosphoketolase pathway dominates in Lactobacillus reuteri ATCC 55730 containing dual pathways for glycolysis. Journal of Bacteriology 2008, 190:206-212.
8. Baldoma L., Aguilar J. Metabolism of L-fucose and L-rhamnose in Escherichia coli: Aerobic-anaerobic regulation of L-lactaldehyde dissimilation. Journal of Bacteriology 1988, 170:416-421.
9. Barboza M., Sela D.A., Pirim C., LoCascio R.G., Freeman S.L., German J.B., Mills D.A., Lebrilla C.B. Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans. Applied and Environmental Microbiology 2009, 75:7319-7325.
10. Bartosch S., Woodmansey E.J., Paterson J.C., McMurdo M.E., Macfarlane G.T. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clinical Infectious Diseases 2005, 40:28-37.
11. Blazewicz S.J., Barnard R.L., Daly R.A., Firestone M.K. Evaluating rRNA as an indicator of microbial activity in environmental communities: Limitations and uses. The ISME Journal 2013, 7:2061-2068.
12. Boronat A., Aguilar J. Metabolism of L-fucose and L-rhamnose in Escherichia coli: Differences in induction of propanediol oxidoreductase. Journal of Bacteriology 1981, 147:181-185.
13. Casas I.A., Dobrogosz W.J. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microbial Ecology in Health and Disease 2000, 12:247-285.
14. Cimperman L., Bayless G., Best K., Diligente A., Mordarski B., Oster M., Smith M., Vatakis F., Wiese D., Steiber A., Katz J. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. Journal of Clinical Gastroenterology 2011, 45:785-789.
15. Coccorullo P., Strisciuglio C., Martinelli M., Miele E., Greco L., Staiano A. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: A double-blind, randomized, placebo-controlled study. The Journal of Pediatrics 2010, 157:598-602.
16. de Weerth C., Fuentes S., de Vos W.M. Crying in infants: On the possible role of intestinal microbiota in the development of colic. Gut Microbes 2013, 4:416-421.
17. Davis L.M., Martinez I., Walter J., Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. International Journal of Food Microbiology 2010, 144:285-292.
18. Dommels Y.E.M., Kemperman R.A., Zebregs Y.E.M.P., Draaisma R.B., Jol A., Wolvers D.A.W., Vaughan E.E., Albers R. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Applied and Environmental Microbiology 2009, 75:6198-6204.
19. Egervärn M., Lindmark H., Olsson J., Roos S. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Antonie van Leeuwenhoek 2010, 97:189-200.
20. Faul F., Erdfelder E., Buchner A., Lang A.-G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods 2009, 41:1149-1160.
21. Flint H.J., Scott K.P., Louis P., Duncan S.H. The role of the gut microbiota in nutrition and health. Nature Reviews Gastroenterology & Hepatology 2012, 9:577-589.
22. Francavilla R., Lionetti E., Castellaneta S., Ciruzzi F., Indrio F., Masciale A., Fontana C., La Rosa M.M., Cavallo L., Francavilla A. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea - A double-blind study. Alimentary Pharmacology & Therapeutics 2012, 36:363-369.
23. Francavilla R., Lionetti E., Castellaneta S.P., Magista A.M., Maurogiovanni G., Bucci N., De Canio A., Indrio F., Cavallo L., Ierardi E., Miniello V.L. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: A pilot study. Helicobacter 2008, 13:127-134.
24. Frank D.N., Pace N.R. Gastrointestinal microbiology enters the metagenomics era. Current Opinion in Gastroenterology 2008, 24:4-10.
25. Frese S.A., Hutkins R.W., Walter J. Comparison of the colonization ability of autochthonous and allochthonous strains of lactobacilli in the human gastrointestinal tract. Advances in Microbiology 2012, 2:399-409.
26. Garrido D., Ruiz-Moyano S., Jimenez-Espinoza R., Eom H.-J., Block D.E., Mills D.A. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiology 2013, 33:262-270.
27. Gänzle M.G., Follador R. Metabolism of oligosaccharides and starch in lactobacilli: A review. Frontiers in Microbiology 2012, 3:340.
28. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 1995, 125:1401-1412.
29. Goin, C. D. (2010). Growth of lactic acid bacteria: Influence of protocooperation, bacteriophage infection and prebiotic carbohydrates. M.S. Thesis. University of Nebraska-Lincoln, Lincoln, NE.
30. Guarner F., Schaafsma G.J. Probiotics. International Journal of Food Microbiology 1998, 39:237-238.
31. Hunter C., Dimaguila M.A.V.T., Gal P., Wimmer J.E., Ransom J.L., Carlos R.Q., Smith M., Davanzo C.C. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: A sequential analysis. BMC Pediatrics 2012, 12:142.
32. Indrio F., Di Mauro A., Riezzo G., Civardi E., Intini C., Corvaglia L., Ballardini E., Bisceglia M., Cinquetti M., Brazzoduro E., Del Vecchio A., Tafuri S., Francavilla R. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: A randomized clinical trial. JAMA Pediatrics 2014, 168:228-233.
33. Indrio F., Riezzo G., Raimondi F., Bisceglia M., Filannino A., Cavallo L., Francavilla R. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. European Journal of Clinical Investigation 2011, 41:417-422.
34. Joint, F. (2001). WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Córdoba, Argentina. October, 1-4.
35. Jones M.L., Martoni C.J., Parent M., Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. The British Journal of Nutrition 2012, 107:1505-1513.
36. Jones M.L., Martoni C.J., Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized controlled trial. European Journal of Clinical Nutrition 2012, 66:1234-1241.
37. Kamada N., Seo S.U., Chen G.Y., Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nature Reviews. Immunology 2013, 13:321-335.
38. Kolida S., Gibson G.R. Synbiotics in health and disease. Annual Review of Food Science and Technology 2011, 2:373-393.
39. Krooneman J., Faber F., Alderkamp A.C., Elferink S.J.H.W.O., Driehuis F., Cleenwerck I., Swings J., Gottschal J.C., Vancanneyt M. Lactobacillus diolivorans sp. nov., a 1,2-propanediol-degrading bacterium isolated from aerobically stable maize silage. International Journal of Systematic and Evolutionary Microbiology 2002, 52:639-646.
40. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Genes and molecules of lactobacilli supporting probiotic action. Microbiology and Molecular Biology Reviews 2008, 72:728-764.
41. Morelli L., Zonenschain D., Callegari M.L., Grossi E., Maisano F., Fusillo M. Assessment of a new synbiotic preparation in healthy volunteers: Survival, persistence of probiotic strains and its effect on the indigenous flora. Nutrition Journal 2003, 2:11.
42. Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. Host-gut microbiota metabolic interactions. Science 2012, 336:1262-1267.
43. Oliva S., Di Nardo G., Ferrari F., Mallardo S., Rossi P., Patrizi G., Cucchiara S., Stronati L. Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Alimentary Pharmacology & Therapeutics 2012, 35:327-334.
44. Panigrahi P., Parida S., Pradhan L., Mohapatra S.S., Misra P.R., Johnson J.A., Chaudhry R., Taylor S., Hansen N.I., Gewolb I.H. Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut. Journal of Pediatric Gastroenterology and Nutrition 2008, 47:45-53.
45. Patel E.H., Paul L.V., Patrick S., Abratt V.R. Rhamnose catabolism in Bacteroides thetaiotaomicron is controlled by the positive transcriptional regulator RhaR. Research in Microbiology 2008, 159:678-684.
46. Rhoads J.M., Fatheree N.Y., Norori J., Liu Y., Lucke J.F., Tyson J.E., Ferris M.J. Altered fecal microflora and increased fecal calprotectin in infants with colic. The Journal of Pediatrics 2009, 155:823-828. e821.
47. Roos S., Dicksved J., Tarasco V., Locatelli E., Ricceri F., Grandin U., Savino F. 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS ONE 2013, 8:e56710.
48. Rosander A., Connolly E., Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Applied and Environmental Microbiology 2008, 74:6032-6040.
49. Saulnier D.M., Santos F., Roos S., Mistretta T.A., Spinler J.K., Molenaar D., Teusink B., Versalovic J. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS ONE 2011, 6:e18783.
50. Savino F., Cordisco L., Tarasco V., Palumeri E., Calabrese R., Oggero R., Roos S., Matteuzzi D. Lactobacillus reuteri DSM 17938 in infantile colic: A randomized, double-blind, placebo-controlled trial. Pediatrics 2010, 126:e526-e533.
51. Savino F., Pelle E., Palumeri E., Oggero R., Miniero R. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: A prospective randomized study. Pediatrics 2007, 119:e124-e130.
52. Shornikova A.V., Casas I.A., Mykkanen H., Salo E., Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. The Pediatric Infectious Disease Journal 1997, 16:1103-1107.
53. Shornikova A.V., Casas I.A., Isolauri E., Mykkanen H., Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. Journal of Pediatric Gastroenterology and Nutrition 1997, 24:399-404.
54. Smith T.J., Anderson D., Margolis L.M., Sikes A., Young A.J. Persistence of Lactobacillus reuteri DSM17938 in the human intestinal tract: Response to consecutive and alternate-day supplementation. Journal of the American College of Nutrition 2011, 30:259-264.
55. Sriramulu D.D., Liang M., Hernandez-Romero D., Raux-Deery E., Lunsdorf H., Parsons J.B., Warren M.J., Prentice M.B. Lactobacillus reuteri DSM 20016 produces cobalamin-dependent diol dehydratase in metabolosomes and metabolizes 1,2-propanediol by disproportionation. Journal of Bacteriology 2008, 190:4559-4567.
56. Szajewska H., Gyrczuk E., Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: A randomized, double-blind, placebo-controlled trial. The Journal of Pediatrics 2013, 162:257-262.
57. Talarico T.L., Axelsson L.T., Novotny J., Fiuzat M., Dobrogosz W.J. Utilization of glycerol as a hydrogen acceptor by Lactobacillus reuteri: Purification of 1,3-propanediol:NAD oxidoreductase. Applied and Environmental Microbiology 1990, 56:943-948.
58. Tannock G.W., Munro K., Bibiloni R., Simon M.A., Hargreaves P., Gopal P., Harmsen H., Welling G. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Applied and Environmental Microbiology 2004, 70:2129-2136.
59. Valeur N., Engel P., Carbajal N., Connolly E., Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Applied and Environmental Microbiology 2004, 70:1176-1181.
60. Wall T., Bath K., Britton R.A., Jonsson H., Versalovic J., Roos S. The early response to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a putative cell wall-altering esterase. Applied and Environmental Microbiology 2007, 73:3924-3935.
61. Walter J., Britton R.A., Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(Suppl. 1):4645-4652.
62. Walter J., Hertel C., Tannock G.W., Lis C.M., Munro K., Hammes W.P. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Applied and Environmental Microbiology 2001, 67:2578-2585.
63. Whitehead K., Versalovic J., Roos S., Britton R.A. Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730. Applied and Environmental Microbiology 2008, 74:1812-1819.
64. Wolf B.W., Garleb K.A., Ataya D.G., Casas I.A. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microbial Ecology in Health and Disease 1995, 8:41-50.
65. Wolf B.W., Wheeler K.B., Ataya D.G., Garleb K.A. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food and Chemical Toxicology 1998, 36:1085-1094.